Stay updated with breaking news from Abbott Trifecta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The U.S. Food and Drug Administration (FDA) is providing an update to the February 27, 2023 Letter to Health Care Providers about the potential risk of early structural valve deterioration (SVD) with Abbott Trifecta valves, including the Trifecta Valve and Trifecta Valve with Glide Technology (GT)
The Food and Drug Administration has issued a safety alert regarding the potential risk of early structural valve deterioration with Abbott Trifecta valves.
Letters sent by the FDA and Abbott warn about a potential risk of early structural valve deterioration with the Abbott Trifecta valve and Trifecta valve with glide technology.
/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA is withdrawing...
The FDA’s Vaccine and Related Biological Products Advisory Committee convenes a two-day meeting today to consider recommending two new respiratory syncytial virus vaccinations for adults 60 years and older.